• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Reprod Immunol . Increasing rates of sars-cov-2 infection in newborns during the omicron variant epoch

tetano

Editor, Senior Moderator
Am J Reprod Immunol


. 2023 Aug;90(2):e13742.
doi: 10.1111/aji.13742. Increasing rates of sars-cov-2 infection in newborns during the omicron variant epoch

Joe Eid[SUP] 1 [/SUP], Sara Post[SUP] 1 [/SUP], Heather Guhde[SUP] 1 [/SUP], Rakhi Gupta Basuray[SUP] 1 [/SUP], Pablo J Sanchez[SUP] 2 [/SUP], Maged M Costantine[SUP] 3 [/SUP], Kara M Rood[SUP] 1 [/SUP]



Affiliations
Abstract

Problem: Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from infected pregnant individuals to the fetus or newborn occurs from 1.2% to 4.3%. Our aim was to determine the rate of positivity among newborns delivered to infected mothers during epochs of different variants predominance.
Method of study: This is a single academic center retrospective cohort study where we reviewed the electronic health records of pregnant individuals who tested positive for SARS-CoV-2 infection and their newborns from March 2020 through January 2022. Infants born to SARS-CoV-2-positive mothers at the time of delivery or within 10 days of admission were tested for SARS-CoV-2 infection at 24-36 h of age.
Results: A total of 195 mothers were positive at delivery or within 10 days of admission and had their newborns tested for SARS-CoV-2. Seven newborns (3.6%) were positive. All positive infants were asymptomatic and born to unvaccinated mothers. Newborn positivity for SARS-CoV-2 was highest during the Omicron epoch (9.4%, p = .01).
Conclusion: Increasing positivity rate was seen during the Omicron variant predominance. This could be attributed to postnatal acquisition of the virus, as Omicron has been associated with higher transmissibility in older children and adults.

Keywords: COVID-19; Omicron variant; newborn.

 
Back
Top Bottom